Group One Trading’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Group One Trading’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-135,018	Closed	-$47K	–	5252
2016 Q3	$47K	Sell	135,018 -831,050	-86%	-$289K	﹤0.01%	3383
2016 Q2	$450K	Buy	+966,068	New	+$450K	0.01%	1811
2016 Q1	–	Sell	-1,346,904	Closed	-$1.98M	–	5504
2015 Q4	$1.98M	Buy	1,346,904 +84,190	+7%	+$124K	0.02%	860
2015 Q3	$2M	Buy	1,262,714 +568,381	+82%	+$898K	0.03%	785
2015 Q2	$1.18M	Buy	694,333 +414,633	+148%	+$705K	0.02%	1088
2015 Q1	$389K	Sell	279,700 -179,252	-39%	-$249K	0.01%	1818
2014 Q4	$693K	Sell	458,952 -80,079	-15%	-$121K	0.01%	1315
2014 Q3	$1.11M	Buy	539,031 +120,403	+29%	+$248K	0.02%	1044
2014 Q2	$1.28M	Sell	418,628 -127,198	-23%	-$389K	0.02%	976
2014 Q1	$1.36M	Buy	+545,826	New	+$1.36M	0.02%	862

Group One Trading's RXII Position: Q4 2016 in Review

Group One Trading sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 135,018 shares — an estimated $47K sold.

Group One Trading first reported a position in RXII in Q1 2014 and held it in 10 quarters. The position peaked at $2M in Q3 2015. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Group One Trading reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Group One Trading sold 135,018 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $47K.
Group One Trading first reported a position in GALENA BIOPHARMA INC COM in Q1 2014 and held it in 10 quarters.
Group One Trading's GALENA BIOPHARMA INC COM position peaked at $2M in Q3 2015.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Group One Trading's 13F filing for Q4 2016, filed 15 Feb 2017.